Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well 3'-deoxy-3'-18F fluorothymidine (18F-FLT) positron
emission tomography (PET)/computed tomography (CT) works in predicting response in patients
receiving chemotherapy and undergoing surgery for breast cancer that has spread from where it
started to nearby tissue or lymph nodes. Diagnostic procedures, such as 18F-FLT PET/CT, may
help in learning how well chemotherapy works to kill breast cancer cells before surgery and
help doctors plan the best treatment.